A patient has received an overdose of intravenous heparin, and is showing signs of excessive bleeding. Which substance is the antidote for heparin overdose.
Rationale:
Protamine sulfate. This substance specifically neutralizes heparin's anticoagulant effects by forming a stable complex with it, thereby effectively reversing the bleeding tendency resulting from an overdose of heparin.
A: Vitamin E. While beneficial for overall health and has antioxidant properties, it does not counteract the effects of heparin or address bleeding complications from its overdose.
B: Vitamin K. This vitamin is essential for synthesizing certain clotting factors but does not interact with heparin, making it ineffective for reversing heparin-induced bleeding.
D: Potassium chloride. This substance is primarily used to manage electrolyte imbalances and has no role in reversing the anticoagulant effects of heparin, thus failing to address the overdose.
A patient shows prolonged prothrombin time and activated partial thromboplastin time. Blood test otherwise is normal. Which of the following is the most probably diagnosis for this patient's condition?
Rationale:
Vitamin K deficiency. This condition leads to impaired synthesis of clotting factors II, VII, IX, and X, resulting in prolonged prothrombin time and activated partial thromboplastin time while maintaining normal blood tests otherwise.
A: Hemophilia A. This disorder primarily affects factor VIII, causing prolonged aPTT without significantly altering prothrombin time, which does not align with the patient's test results.
B: Thrombocytopenia. This condition involves a reduced platelet count that primarily leads to bleeding and does not specifically prolong prothrombin time or aPTT, unlike the patient's findings.
C: Von Willebrand factor disease. This disease mainly affects factor VIII and platelet function, typically resulting in normal prothrombin time, making it inconsistent with the observed prolonged coagulation times in this case.
Which of the following is not associated with thrombotic thrombocytopenic purpura?
Rationale:
Thrombosis is not associated with thrombotic thrombocytopenic purpura. TTP primarily features a deficiency in the von Willebrand factor-cleaving protease, leading to thrombocytopenia, microangiopathic hemolytic anemia, and neurologic deficits rather than thrombosis itself.
B: thrombocytopenia This condition is a hallmark of TTP, resulting from the destruction of platelets due to abnormal clotting processes within small blood vessels.
C: microangiopathic hemolytic anemia TTP is characterized by microangiopathic hemolytic anemia, which occurs due to the fragmentation of red blood cells as they pass through obstructed microvasculature.
D: neurologic deficits Neurologic deficits are common in TTP, stemming from the effects of microvascular occlusion and reduced blood flow to the brain, leading to various neurological symptoms.
Which fibrinolytic drug(s) is/are antigenic
Rationale:
Streptokinase is antigenic. The context indicates that streptokinase can provoke an immune response due to its foreign protein nature, leading to the production of antibodies against it, unlike other fibrinolytic agents.
B: Urokinase lacks significant antigenic properties, as it is derived from human sources, making it less likely to elicit an immune response compared to streptokinase.
C: Alteplase is a recombinant tissue plasminogen activator that is designed to minimize antigenicity, thereby reducing the likelihood of an immune reaction in patients receiving treatment.
D: Both (a) and (b) suggests that both drugs are antigenic, but only streptokinase has this property, as urokinase is less likely to provoke an immune response.
Oral iron supplements are given for iron deficiency anaemia. Which of the statement is true regarding the absorption of oral iron supplements?
Rationale:
Absorption is better in the ferrous form than in ferric form. The ferrous form of iron (Fe2+) is more soluble and readily absorbed in the intestines compared to the ferric form (Fe3+), enhancing its bioavailability and effectiveness in treating iron deficiency anemia.
A: Absorption occurs in the large intestine. Oral iron absorption primarily occurs in the duodenum and upper jejunum, where the acidic environment facilitates the solubility of iron.
B: Intrinsic factor is necessary for the iron absorption. Intrinsic factor is essential for vitamin B12 absorption in the intestines, not for iron, which relies on different mechanisms for uptake.
D: Absorption is increased in hereditary haemochromatosis. In hereditary hemochromatosis, iron absorption is often dysregulated and excessively high, leading to iron overload rather than increased absorption efficiency.
A nurse is treating a patient who's been prescribed glucocorticoids to help control airway mucus production and improve breathing. To avoid bone loss that can occur when Prednisone is used for 10 days or more, the nurse should
Rationale:
Using the lowest dose possible to control manifestations minimizes the risk of bone loss associated with glucocorticoid therapy. This strategy balances effective treatment while reducing adverse effects on bone density, especially important for prolonged use.
B: Giving PO Prednisone on a consistent daily dosing schedule may lead to higher cumulative exposure, increasing the risk of bone loss rather than mitigating it through careful dosing strategies.
C: Counseling the patient to consume a diet with less calcium could contribute to further bone density loss, counteracting the protective measures needed while on glucocorticoids and exacerbating osteoporosis risk.
D: Refraining from weight bearing exercises limits beneficial impacts on bone health, as such activities are essential for maintaining bone density, especially important for patients on glucocorticoid therapy.
For patients taking warfarin, international normalized ratios (INRs) are best drawn:
Rationale:
For patients taking warfarin, international normalized ratios (INRs) are best drawn in the morning if the patient takes their warfarin at night. Drawing INRs in the morning ensures that the levels reflect the drug's effect after the overnight dosing period, providing a more accurate assessment of anticoagulation status and minimizing fluctuations due to timing discrepancies.
A: Monthly throughout therapy. Monthly testing may not adequately monitor INR levels, risking potential complications from under- or over-anticoagulation, especially given warfarin’s narrow therapeutic window.
B: Three times a week throughout therapy. Testing this frequently might lead to unnecessary stress and inconvenience for the patient without significantly improving the management of anticoagulation therapy.
C: Two hours after the last dose of warfarin to get an accurate peak level. This timing does not provide a stable measurement of INR, as warfarin's effects can vary widely outside this narrow window.
Initiation of unfractionated heparin therapy for the patient in question 1 would best be achieved with
Rationale:
A: 5000-unit loading dose followed by 1000 units/hr.
This regimen provides an effective initial dose to quickly achieve therapeutic anticoagulation, followed by a continuous infusion that maintains adequate heparin levels for patient safety and efficacy.
B: 5000-unit loading dose followed by 1800 units/hr.
This option offers a higher infusion rate, which may increase the risk of bleeding complications without providing additional therapeutic benefit compared to the standard regimen.
C: 8000-unit loading dose followed by 1800 units/hr.
The higher loading dose could lead to an excessive anticoagulation effect, increasing the likelihood of adverse reactions while not aligning with established protocols for heparin therapy.
D: 8000-unit loading dose followed by 1000 units/hr.
Similar to option C, the excessive loading dose poses significant risks, and the infusion rate does not optimize patient management when compared to the standard recommended approach.
Dophle bodies are patches of dilated endoplasmic reticulum that appear as cerulean blue cytoplasmic puddles. These findings are mostly seen in
Rationale:
Dophle bodies are patches of dilated endoplasmic reticulum that appear as cerulean blue cytoplasmic puddles. These findings are mostly seen in leukaemoid reaction.
Leukaemoid reaction involves an exaggerated response of the bone marrow to stress, often leading to the formation of Dophle bodies, which indicate heightened hematopoietic activity and cellular alterations that characterize this condition.
A: Chronic myeloid leukaemia. This condition primarily features myeloid lineage proliferation and does not typically present with the distinctive Dophle bodies seen in leukaemoid reactions.
C: Chediak Higashi syndrome. Characterized by immunodeficiency and neurological symptoms, this syndrome does not display the Dophle bodies associated with the leukaemoid reaction's cellular changes.
D: Infectious mononucleosis. This viral infection is known for atypical lymphocytes and does not exhibit the specific cytoplasmic puddles indicative of Dophle bodies found in leukaemoid reactions.
How long after the onset of thrombotic symptoms should the use of thrombolytic agents take place?
Rationale:
Thrombolytic agents should be administered within 6 hours after the onset of thrombotic symptoms. This time frame optimizes the chances of successful intervention and minimizes potential complications associated with delayed treatment.
A: Within 3 hours. While early intervention is beneficial, a 3-hour window is often too restrictive and may not align with clinical guidelines for many thrombotic events.
C: Within 9 hours. Waiting 9 hours could significantly reduce the effectiveness of thrombolytic therapy, increasing the risk of permanent damage or complications associated with the thrombus.
D: Within 12 hours. A 12-hour delay greatly diminishes the likelihood of successful thrombolysis, as the thrombus may become more organized and less amenable to treatment at this stage.
The average starting dose of warfarin is 5 mg daily. Higher doses of 7.5 mg daily should be considered in which patients?
Rationale:
Overweight or obese patients benefit from higher doses of warfarin, such as 7.5 mg daily, due to their increased body mass, which can require adjustments in anticoagulant therapy for effective management.
A: Pregnant women require careful anticoagulation management often leading to lower doses of warfarin due to potential risks to the fetus and variations in metabolism during pregnancy.
B: Elderly men typically metabolize medications differently, often necessitating lower doses of warfarin to avoid complications and ensure safety in this age group.
D: Patients with multiple comorbidities often need individualized treatment plans, and higher doses of warfarin may not be universally appropriate due to varying health considerations and potential interactions.
A peripheral blood smear showing increase in numbers of neutrophils, band cells, metamyelocytes, myelocytes, basophils, eosinophils and platelets is most suggestive
Rationale:
A peripheral blood smear showing an increase in numbers of neutrophils, band cells, metamyelocytes, myelocytes, basophils, eosinophils, and platelets is most suggestive of chronic myelocytic leukaemia.
Chronic myelocytic leukaemia is characterized by a sustained increase in myeloid cells, including neutrophils and their precursors, as well as elevated platelet counts, indicating a chronic phase of myeloproliferative disorder.
A: Acute myeloid leukaemia displays rapid proliferation of immature cells and does not typically show the mature cell types present in this smear.
B: Acute lymphoid leukaemia primarily involves lymphoblasts and does not exhibit the diverse myeloid lineage changes noted here.
D: Chronic lymphocytic leukaemia is marked by an increase in small, mature lymphocytes, lacking the myeloid and granulocytic features seen in the smear.
If a patient is taking darbepoetin alfa (Aranesp), their blood counts should be monitored to determine if a dosage adjustment is needed. How soon should this be done after starting the drug?
Rationale:
A: Six weeks if they are a cancer patient. Monitoring blood counts after six weeks is essential for cancer patients on darbepoetin alfa to assess efficacy and adjust dosages effectively, ensuring optimal treatment outcomes.
B: One week if they have chronic renal failure. Monitoring after only one week may not provide sufficient data to evaluate the drug's impact on blood counts in patients with chronic renal failure.
C: Two weeks if they are taking it for allogenic transfusion. A two-week interval is inadequate for accurate assessment, as adjustments require a longer observation period to ensure proper efficacy and safety.
D: Each week throughout therapy. Weekly monitoring is excessive and impractical, as it would not yield significant changes in blood counts early in the treatment course.
A nursing student is reviewing mechanisms of drug action. Which of the following matches the MOA of glucocorticoids?
Rationale:
Glucocorticoids prevent inflammation, suppress airway mucus production, and promote responsiveness of beta2 receptors. This mechanism is critical for reducing airway inflammation and improving respiratory function in conditions like asthma.
B: Prevents inflammation, suppresses gastrointestinal mucus production, and promotes responsiveness of the duodenal lining. This does not align with glucocorticoid action, which primarily targets respiratory pathways rather than gastrointestinal responses.
C: Prevents inflammation, suppresses cerebrospinal fluid production, and promotes responsiveness of the frontal lobe of the brain. Glucocorticoids do not specifically influence cerebrospinal fluid production or brain responsiveness in this manner.
D: None of the listed are correct since glucocorticoids are diuretic. Glucocorticoids are not diuretics; their primary role involves modulating inflammation and immune responses rather than affecting fluid balance.
A patient has been prescribed warfarin (Coumadin) in addition to a heparin infusion. The patient asks the nurse why he has to be on two medications. The nurse's response is based on which rationale?
Rationale:
Heparin is used to start anticoagulation so as to allow time for the blood levels of warfarin to reach adequate levels. This combination ensures immediate anticoagulation while warfarin takes several days to achieve therapeutic effects, thus preventing clot formation during the transition process.
B: Oral anticoagulants are used to reach an adequate level. This option overlooks the necessity of immediate action that heparin provides before warfarin becomes effective, which is critical for patient safety.
Expected pharmacological action of which of the following medications works by binding with and inhibiting thrombin, thus preventing a thrombus from developing?
Rationale:
Direct thrombin inhibitors bind to thrombin, inhibiting its activity and preventing thrombus formation. This mechanism is crucial in anticoagulation therapy, effectively reducing the risk of clot-related complications.
B: Vitamin K inhibitors target the synthesis of clotting factors dependent on vitamin K, which does not involve direct interaction with thrombin, thus failing to prevent thrombus formation through this pathway.
C: B2 Adrenergic receptor agonists primarily influence bronchodilation and do not engage with the coagulation pathway directly, lacking any role in thrombus prevention through thrombin inhibition.
D: N/A indicates no relevant option provided, which fails to address the question about medications that specifically bind to and inhibit thrombin for anticoagulation purposes.
An LPN attending to chronic hypertensive elderly patients at the local skilled nursing facility should remember that use of beta adrenergic blockers can negate effects of
Rationale:
Beta 2 adrenergic agonists. In elderly patients with chronic hypertension, beta adrenergic blockers may counteract the effects of beta 2 agonists, which are essential for bronchodilation and improving respiratory function.
B: Bronchodilators. Not all bronchodilators are beta 2 agonists; some may work through different mechanisms, hence not all would be affected by beta adrenergic blockers.
C: Both. This option suggests that both categories are negated, overlooking that only beta 2 agonists are primarily influenced by beta adrenergic blockers, leaving other bronchodilator classes unaffected.
D: Neither. As this implies that beta adrenergic blockers have no impact, it neglects the specific interaction with beta 2 adrenergic agonists, which can significantly hinder their therapeutic benefits.
Which of the following medications requires obtaining baseline prothrombin time (PT) and monitoring levels of PT and international normalized ratio (INR) periodically?
Rationale:
Vitamin K inhibitors require obtaining baseline prothrombin time (PT) and monitoring PT and international normalized ratio (INR) periodically to ensure safe and effective anticoagulation, preventing complications associated with over- or under-anticoagulation.
A: Enoxaparin Monitoring of PT and INR is not necessary for enoxaparin, which primarily uses anti-factor Xa levels for dosage adjustments and does not involve vitamin K interactions.
B: Fondaparinux Similar to enoxaparin, fondaparinux does not require PT and INR monitoring, as it acts through factor Xa inhibition and is not affected by vitamin K levels.
D: Heparin While heparin does require monitoring, it focuses on activated partial thromboplastin time (aPTT) rather than PT and INR, making it unsuitable for this specific question.
Caution should be taken regarding clients who have been prescribed guaifenesin in the presence of asthma diagnosis because
Rationale:
Caution should be taken regarding clients who have been prescribed guaifenesin in the presence of asthma diagnosis because guaifenesin can cause bronchospasm. This medication may lead to airway tightening, which can exacerbate asthma symptoms and compromise respiratory function, necessitating careful monitoring and potential alternative treatments for affected individuals with underlying respiratory conditions.
B: guaifenesin can cause bronchoconstriction. While bronchoconstriction implies narrowing of airways, guaifenesin primarily induces bronchospasm, which is more relevant in asthma cases, making this option less precise.
C: guaifenesin can cause decreased diameter of bronchial lumina. Decreased diameter of bronchial lumina is a consequence of bronchospasm, but the answer does not specifically address the direct effect associated with guaifenesin in asthma patients.
D: All of the above. Although each statement reflects a potential airway response, only bronchospasm directly links to guaifenesin's action, rendering this option overly broad and inaccurate in context.
A patient is presented with weakness of legs, arms, trunk, tingling and numbness that progressively worsens. Peripheral blood smear shows macrocytic anemia. Which of the following is not the factor causing this condition?
Rationale:
A: Chronic atrophic gastritis Chronic atrophic gastritis impairs the absorption of vitamin B12, leading to macrocytic anemia and neurological symptoms. This condition contributes significantly to the patient's weakness and sensory disturbances.
B: Ileal resection The ileum is essential for vitamin B12 absorption. Resection of this area disrupts nutrient uptake, resulting in macrocytic anemia and associated neurological deficits in the patient.
C: Tapeworm infestation Certain tapeworms can lead to vitamin B12 deficiency by competing for absorption in the intestines, causing macrocytic anemia and the observed symptoms of numbness and tingling.
D: Alcoholism Alcoholism primarily affects liver function and does not directly cause macrocytic anemia through B12 deficiency, making it an unlikely factor in this patient's symptoms and condition.
A nurse is attempting to relieve her patient's bronchospasm with Ipratropium should understand that the expected mechanism of action for this medication is
Rationale:
Blocking muscarinic receptors of the bronchi, resulting in bronchodilation.
Ipratropium works by inhibiting muscarinic receptors in the bronchial smooth muscle, leading to relaxation and widening of the airways. This mechanism counteracts bronchospasm, facilitating easier airflow and improved respiratory function, making it effective for conditions like asthma and COPD.
A: Antagonizing b2 adrenergic receptors of the bronchi, resulting in bronchoconstriction. This option misrepresents Ipratropium’s action as it does not target b2 adrenergic receptors, which are associated with bronchodilation, not bronchoconstriction.
C: Agonizing muscarinic receptors of the bronchi, resulting in bronchodilation. This choice erroneously suggests that Ipratropium stimulates muscarinic receptors, while it actually blocks them, preventing bronchoconstriction and promoting airflow.
D: Antagonizing a 1 adrenergic receptors of the myocardium. This alternative incorrectly focuses on cardiac receptors, which are unrelated to bronchial function, thus failing to address the medication's intended effects on bronchospasm.
A patient will be receiving a thrombolytic drug as part of the treatment for acute myocardial infarction. The nurse explains to the patient that this drug is used for which purpose?
Rationale:
To dissolve the clot in the coronary artery. Thrombolytic drugs are specifically designed to break down blood clots that obstruct coronary arteries, thereby restoring blood flow and minimizing heart muscle damage during an acute myocardial infarction.
A: To control bleeding in the coronary vessels. Control of bleeding is not the primary action of thrombolytics; their main function involves clot dissolution, not managing hemorrhage.
C: To relieve chest pain. While alleviating chest pain may occur after clot dissolution, thrombolytics do not directly target pain relief as their primary therapeutic objective.
D: To prevent further clot formation. Thrombolytics focus on dissolving existing clots rather than preventing new ones; anticoagulants are typically used for preventing additional clot formation.
Heparin, an anticoagulant and naturally occurring glycosaminoglycan, exerts its pharmacological effects on the clotting cascade by activating antithrombin, thus indirectly inactivating both
Rationale:
Heparin activates antithrombin, leading to the inactivation of thrombin and factor Xa, which are crucial components of the coagulation cascade. This mechanism effectively prevents clot formation and maintains proper blood flow.
B: prothrombin and factor X. Prothrombin is not directly inactivated by heparin; instead, it is thrombin that acts on prothrombin, making this option factually inaccurate.
C: von Willebrand factor and factor IX. Heparin does not target von Willebrand factor, which is involved in platelet adhesion, nor does it directly inactivate factor IX.
D: Tissue factor and factor XIa. Tissue factor initiates the extrinsic pathway of coagulation, and heparin does not directly affect this pathway or factor XIa’s function in the cascade.
Anticoagulants are indicated in
Rationale:
Anticoagulants are indicated in all of these conditions. Their role in preventing blood clots is crucial for immobilized elderly patients, managing complications in Buerger's disease, and reducing stroke risk from cerebral thrombosis.
A: Immobilized elderly patients. They are at heightened risk for venous thromboembolism, making anticoagulants essential for prevention and management in this vulnerable group.
B: Buerger's disease. While treatment focuses on smoking cessation and managing symptoms, anticoagulants do not address the underlying vascular issues directly related to this condition.
C: Stroke due to cerebral thrombosis. Although anticoagulants can be beneficial in some stroke scenarios, they are not universally indicated and depend on specific stroke characteristics.
A 50 year old male who had frequent infections of his upper respiratory tract manifested with subcutaneous petechiae over his arms and legs. Investigations revealed low haemoglobin and a dry tap marrow. The most likely condition the patient is suffering from
Rationale:
Aplastic anaemia. The patient’s symptoms, including frequent infections and subcutaneous petechiae, alongside low haemoglobin and a dry tap marrow, strongly indicate aplastic anaemia, characterized by bone marrow failure and reduced blood cell production.
A: Iron deficiency anaemia. This condition typically presents with microcytic anemia and does not account for the patient's symptoms of infections and petechiae due to low blood cell production.
B: Megaloblastic anaemia. Primarily caused by vitamin B12 or folate deficiency, it results in macrocytic anemia, which does not align with the patient's presentation of low haemoglobin and marrow findings.
C: Haemolytic anaemia. Characterized by the destruction of red blood cells, it would not explain the patient's symptoms of infections and the dry tap marrow indicating a lack of production.
Which of the following PO beta2 adrenergic agonists is used for long term control of chronic COPD as well as for emergency IV treatment of bronchospasms?
Rationale:
D: Albuterol is utilized for both long-term management of chronic COPD and for emergency intravenous treatment of bronchospasms. Its dual functionality makes it a vital medication in respiratory care.
A: Theophylline primarily serves as a maintenance therapy for asthma and COPD but lacks immediate effectiveness in acute bronchospasm situations, limiting its use in emergencies.
B: Acetylcysteine acts as a mucolytic agent to reduce mucus viscosity but does not possess bronchodilator properties, rendering it ineffective for treating bronchospasms or chronic COPD management.
C: Codeine functions as an opioid cough suppressant and does not address bronchospasms or chronic obstructive pulmonary disease, making it unsuitable for either long-term control or emergency treatment.
The typical Reed-Sternberg cells are either infrequent or absent. Instead, lymphocytic and histiocytic cells or “popcorn cells†are seen within a background of inflammatory cells, which are predominantly benign lymphocytes. Which type of Hodgkin's lymphoma best suit the description?
Rationale:
Lymphocyte predominance best suits the description. This subtype is characterized by the presence of lymphocytic and histiocytic cells or “popcorn cells” in a background filled with predominantly benign lymphocytes, rather than Reed-Sternberg cells.
A: Nodular sclerosis features a predominance of Reed-Sternberg cells and fibrous bands, which contrasts sharply with the absence of these cells in the described scenario.
B: Mixed cellularity typically includes a variety of cell types, including Reed-Sternberg cells, which does not align with the description of infrequent or absent Reed-Sternberg cells.
C: Lymphocyte depleted is marked by a significant reduction in lymphocytes, often leading to a more aggressive disease, which directly contradicts the presence of benign lymphocytes in the context.
Which of the following is the most suitable anti malarial drug for pregnant women?
Rationale:
Quinine and clindamycin is the most suitable anti-malarial drug for pregnant women. This combination is considered safe and effective during pregnancy, providing an appropriate treatment option that minimizes risks to both the mother and fetus while addressing malaria effectively.
A: Atovaquone and proguanil lack sufficient safety data in pregnancy, making them a less favored choice for treating malaria in pregnant women who require reliable and safe medication options.
B: Quinine and doxycycline poses risks during pregnancy, as doxycycline can affect fetal development, making this combination unsuitable for pregnant women needing malaria treatment.
D: Primaquine is contraindicated in pregnancy, as it can cause hemolytic anemia in infants, thus presenting significant safety concerns for use in pregnant women needing anti-malarial therapy.
After seven days of treatment with sulfonamides a patient's haemoglobin had decreased from 14.7 gm/100 ml to 10 gm/100 ml. The most likely cause of hemolysis in this patient is
Rationale:
D: Glucose 6-phosphate dehydrogenase deficiency (G6PD) is the most likely cause of hemolysis in this patient due to the known association between sulfonamides and oxidative stress, which can lead to red blood cell destruction in individuals with G6PD deficiency.
A: Sickle cell disease primarily involves abnormal hemoglobin causing vaso-occlusive crises, not direct hemolysis from medication. The patient's sudden drop in hemoglobin points away from this condition.
B: Thalassemia minor typically results in mild microcytic anemia without acute hemolysis. The significant drop in hemoglobin after sulfonamide treatment does not align with thalassemia's chronic presentation.
C: Hereditary spherocytosis features structural abnormalities of red blood cells, leading to hemolysis, but does not correlate directly with sulfonamide reactions. The rapid decrease in hemoglobin suggests a different underlying pathology.
Which of the following is false regarding Burkitt's lymphoma?
Rationale:
Burkitt's lymphoma is associated with the translocation of the c-myc gene on chromosome 8, not chromosome 18. This genetic alteration is crucial for the rapid growth characteristic of this aggressive lymphoma.
B: Usually presents with abdominal involvement in HIV patients. While Burkitt's lymphoma can affect HIV patients, abdominal involvement is not a defining feature, as symptoms can vary widely.
C: Common in African children due to Epstein Barr infection after malaria exposure. Although prevalent in African children, the link to malaria exposure is not exclusively responsible for the disease's occurrence, as other factors contribute.
D: Histologically characterized by a "starry sky" appearance. The "starry sky" pattern is indeed a hallmark of Burkitt's lymphoma, reflecting the presence of macrophages within the tumor, indicating its typical histological features.
A patient has received an overdose of intravenous heparin, and is showing signs of excessive bleeding. Which substance is the antidote for heparin overdose.
Rationale:
Protamine sulfate. This substance acts as a specific antidote for heparin by neutralizing its anticoagulant effects, effectively reversing the risk of excessive bleeding in patients receiving heparin therapy.
A: Vitamin E. While beneficial for various health issues, it does not play a role in counteracting heparin’s effects or managing overdose situations effectively.
B: Vitamin K. This vitamin is essential for synthesizing clotting factors but does not interact with heparin, making it ineffective in reversing heparin-induced coagulation issues.
D: Potassium chloride. Primarily used to treat potassium deficiency, it has no relevance in addressing heparin overdose or controlling bleeding complications associated with anticoagulant therapy.
A patient shows prolonged prothrombin time and activated partial thromboplastin time. Blood test otherwise is normal. Which of the following is the most probably diagnosis for this patient's condition?
Rationale:
Vitamin K deficiency. This condition leads to prolonged prothrombin time and activated partial thromboplastin time due to its essential role in synthesizing clotting factors II, VII, IX, and X, which are crucial for proper coagulation.
A: Hemophilia A primarily affects factor VIII, causing prolonged aPTT but not prothrombin time, which remains normal in this disorder.
B: Thrombocytopenia involves a low platelet count, impacting bleeding risk, but does not directly alter prothrombin time or aPTT.
C: Von Willebrand factor disease mainly affects factor VIII stability and platelet function, not prothrombin time, resulting in different laboratory findings than those presented.
Which of the following is not associated with thrombotic thrombocytopenic purpura?
Rationale:
Thrombosis is not associated with thrombotic thrombocytopenic purpura. TTP primarily involves thrombocytopenia, microangiopathic hemolytic anemia, and neurologic deficits, which are hallmark features of the disease, while thrombosis is not a defining characteristic.
B: thrombocytopenia This condition is a major feature of TTP, characterized by a low platelet count leading to bleeding and bruising, directly impacting the patient's health status.
C: microangiopathic hemolytic anemia This form of anemia results from the destruction of red blood cells in small vessels, a key aspect of TTP, contributing to the clinical picture of the disorder.
D: neurologic deficits Neurologic symptoms occur in TTP due to microvascular occlusion and resultant ischemia, making these deficits significant indicators of the disease's severity and impact on the nervous system.
Which fibrinolytic drug(s) is/are antigenic
Rationale:
Streptokinase is antigenic.
Streptokinase, derived from streptococci bacteria, elicits an immune response due to its foreign protein structure, making it antigenic. This characteristic can lead to the development of antibodies in patients, potentially reducing its effectiveness upon repeated administration. Urokinase and alteplase do not share this property, making streptokinase unique in its antigenic nature among fibrinolytic agents.
B: Urokinase Urokinase does not provoke an immune response, as it is derived from human sources, making it non-antigenic compared to streptokinase.
C: Alteplase Alteplase, a recombinant tissue plasminogen activator, is designed to minimize antigenicity, thus not triggering significant immune responses like streptokinase does.
D: Both (a) and (b) This option falsely includes urokinase, which lacks the antigenic properties associated with streptokinase, making the combination inaccurate.
Oral iron supplements are given for iron deficiency anaemia. Which of the statement is true regarding the absorption of oral iron supplements?
Rationale:
Absorption is better in the ferrous form than in ferric form. Ferrous iron is more soluble and readily absorbed in the intestines, enhancing its bioavailability for effective treatment of iron deficiency anaemia.
A: Absorption occurs in the large intestine. Iron absorption primarily takes place in the duodenum and upper jejunum, not in the large intestine where nutrient absorption is minimal.
B: Intrinsic factor is necessary for the iron absorption. Intrinsic factor is crucial for vitamin B12 absorption, not iron, which relies on different mechanisms for uptake in the gastrointestinal tract.
D: Absorption is increased in hereditary haemochromatosis. In hereditary haemochromatosis, iron absorption is typically excessive rather than increased, leading to iron overload rather than enhanced absorption efficiency.
A nurse is treating a patient who's been prescribed glucocorticoids to help control airway mucus production and improve breathing. To avoid bone loss that can occur when Prednisone is used for 10 days or more, the nurse should
Rationale:
Using the lowest dose possible to control manifestations minimizes the risks associated with prolonged glucocorticoid use, such as bone loss. This approach effectively balances treatment efficacy while protecting the patient's bone health.
B: Giving PO Prednisone on a consistent daily dosing schedule maintains stable drug levels but does not address the critical issue of minimizing dosage to prevent bone loss.
C: Counseling the patient to consume a diet with less calcium fails to support bone health; instead, increasing calcium intake is essential to counteract potential bone density reduction from glucocorticoids.
D: Refraining from weight-bearing exercises limits physical activity, which is vital for maintaining bone strength and density, especially when glucocorticoids are involved. Regular exercise is beneficial.
For patients taking warfarin, international normalized ratios (INRs) are best drawn:
Rationale:
D: In the morning if the patient takes their warfarin at night. This timing allows for the most accurate measurement of INR, reflecting the medication's effect after the overnight absorption and metabolism period.
A: Monthly throughout therapy. This frequency may not adequately monitor INR fluctuations, risking potential complications associated with inconsistent anticoagulation levels in patients on warfarin.
B: Three times a week throughout therapy. Such frequent testing could lead to unnecessary patient burden and healthcare costs, while still not providing optimal monitoring tailored to individual response.
C: Two hours after the last dose of warfarin to get an accurate peak level. This timing fails to capture the INR’s relevant therapeutic range, as peak levels do not reflect steady-state anticoagulation.
Initiation of unfractionated heparin therapy for the patient in question 1 would best be achieved with
Rationale:
A: 5000-unit loading dose followed by 1000 units/hr. This regimen is optimal for initiating unfractionated heparin therapy, balancing effective anticoagulation with safety, ensuring rapid therapeutic levels without excessive risk of bleeding.
B: 5000-unit loading dose followed by 1800 units/hr. This dosing increases the risk of over-anticoagulation, potentially leading to complications such as bleeding, which is not advisable for initial therapy.
C: 8000-unit loading dose followed by 1800 units/hr. The higher loading dose may cause an unnecessary surge in anticoagulation levels, increasing the likelihood of adverse effects, particularly bleeding events.
D: 8000-unit loading dose followed by 1000 units/hr. This approach initiates treatment with an excessive loading dose, which can lead to heightened bleeding risk without correlating benefits in anticoagulation efficacy.
Dophle bodies are patches of dilated endoplasmic reticulum that appear as cerulean blue cytoplasmic puddles. These findings are mostly seen in
Rationale:
Dophle bodies are patches of dilated endoplasmic reticulum that appear as cerulean blue cytoplasmic puddles. These findings are mostly seen in leukaemoid reaction.
The leukaemoid reaction features heightened white blood cell production, often resulting in Dophle bodies due to the increased synthesis of proteins and organelles within immature cells. This phenomenon is linked to reactive processes, distinguishing it from other options where such features are absent or less common.
A: Chronic myeloid leukaemia exhibits myeloid proliferation but typically does not present Dophle bodies, as the pathophysiology differs significantly in terms of cellular morphology and maturation stages.
C: Chediak Higashi syndrome is characterized by immunodeficiency and neurological issues, with distinct cellular features, but does not commonly show Dophle bodies in its pathogenesis or clinical presentation.
D: Infectious mononucleosis primarily involves atypical lymphocytes and does not feature Dophle bodies, as its cellular changes and manifestations are focused on lymphocyte activation rather than endoplasmic reticulum dilation.
How long after the onset of thrombotic symptoms should the use of thrombolytic agents take place?
Rationale:
Thrombolytic agents should be administered within 6 hours after the onset of thrombotic symptoms. This timeframe is critical for maximizing the effectiveness of treatment and minimizing potential complications associated with delayed intervention.
A: Within 3 hours. This option is too restrictive, as effective treatment can still occur beyond this short timeframe, allowing for a broader therapeutic window.
C: Within 9 hours. Waiting until 9 hours may significantly reduce the likelihood of successful thrombolysis, increasing the risk of long-term complications and poor outcomes.
D: Within 12 hours. Delaying treatment until 12 hours after symptoms onset can lead to irreversible damage, making thrombolysis less effective and potentially hazardous for patient recovery.
The average starting dose of warfarin is 5 mg daily. Higher doses of 7.5 mg daily should be considered in which patients?
Rationale:
Higher doses of 7.5 mg daily should be considered in overweight or obese patients. This population may require increased anticoagulation due to higher body mass, which can influence warfarin metabolism and necessitate adjustments in dosing for effective therapeutic outcomes.
A: Pregnant women Higher doses are generally avoided in pregnant women to minimize risks to fetal development, as warfarin can cross the placenta and lead to complications.
B: Elderly men Increased sensitivity and potential for drug interactions in elderly men often necessitate lower doses rather than higher, to avoid heightened risk of bleeding and adverse effects.
D: Patients with multiple comorbidities Higher doses aren't automatically recommended for patients with multiple comorbidities, as their complex health status may necessitate more cautious dosing to avoid complications.
A peripheral blood smear showing increase in numbers of neutrophils, band cells, metamyelocytes, myelocytes, basophils, eosinophils and platelets is most suggestive
Rationale:
A peripheral blood smear showing an increase in numbers of neutrophils, band cells, metamyelocytes, myelocytes, basophils, eosinophils, and platelets is most suggestive of chronic myelocytic leukaemia.
This option correctly reflects a myeloproliferative disorder characterized by the overproduction of myeloid cells, including neutrophils and their precursors, along with elevated platelet counts, indicative of chronic myeloid leukaemia.
A: Acute myeloid leukaemia features a rapid increase in immature myeloid cells but does not typically present with the chronic elevation of mature forms seen in this scenario.
B: Acute lymphoid leukaemia primarily affects lymphoid cells, leading to lymphoblast proliferation, which does not align with the myeloid predominance observed in the smear description.
D: Chronic lymphocytic leukaemia is characterized by the proliferation of mature lymphocytes rather than myeloid cells, making it inconsistent with the findings of increased neutrophils and their precursors.
If a patient is taking darbepoetin alfa (Aranesp), their blood counts should be monitored to determine if a dosage adjustment is needed. How soon should this be done after starting the drug?
Rationale:
A: Six weeks if they are a cancer patient. Monitoring blood counts after six weeks is crucial for cancer patients receiving darbepoetin alfa, allowing adequate time to assess the drug's effectiveness and adjust the dosage appropriately based on their hematological response.
B: One week if they have chronic renal failure. A one-week interval may not provide sufficient time for the drug to show its effects in patients with chronic renal failure.
C: Two weeks if they are taking it for allogenic transfusion. Two weeks does not align with the recommended monitoring timeframe, which is longer to ensure proper evaluation of treatment impacts.
D: Each week throughout therapy. Weekly monitoring is excessive and unnecessary; a longer interval is appropriate for determining dosage adjustments in the treatment regimen.
A nursing student is reviewing mechanisms of drug action. Which of the following matches the MOA of glucocorticoids?
Rationale:
Glucocorticoids prevent inflammation, suppress airway mucus production, and promote responsiveness of beta2 receptors. This mechanism is crucial in managing conditions like asthma, where reducing inflammation and enhancing airway function are essential for effective treatment.
B: Prevents inflammation, suppresses gastrointestinal mucus production, and promotes responsiveness of the duodenal lining. This option inaccurately describes the primary effects of glucocorticoids, which focus on respiratory rather than gastrointestinal functions.
C: Prevents inflammation, suppresses cerebrospinal fluid production, and promotes responsiveness of the frontal lobe of the brain. This choice misrepresents glucocorticoid action, as their primary role is not related to cerebrospinal fluid or brain responsiveness.
D: None of the listed are correct since glucocorticoids are diuretic. This statement mischaracterizes glucocorticoids, which are primarily anti-inflammatory agents and not classified as diuretics.
A patient has been prescribed warfarin (Coumadin) in addition to a heparin infusion. The patient asks the nurse why he has to be on two medications. The nurse's response is based on which rationale?
Rationale:
Heparin is used to start anticoagulation so as to allow time for the blood levels of warfarin to reach adequate levels. This combination ensures immediate anticoagulation effects while warfarin takes several days to achieve therapeutic levels, providing a seamless transition in treatment.
B: Oral anticoagulants are used to reach an adequate level. This option overlooks the necessity of immediate anticoagulation provided by heparin, which is crucial during the initial phase of warfarin therapy.
Expected pharmacological action of which of the following medications works by binding with and inhibiting thrombin, thus preventing a thrombus from developing?
Rationale:
Direct thrombin inhibitors bind with thrombin, directly inhibiting its activity and thereby preventing the formation of a thrombus, which is essential for effective anticoagulant therapy in various clinical settings.
B: Vitamin K inhibitors Target the synthesis of clotting factors dependent on vitamin K, which does not involve direct interaction with thrombin and thus does not prevent thrombus development directly.
C: B2 Adrenergic receptor agonists Primarily act on the respiratory system and cardiac function, having no relation to thrombin or thrombus formation, and are not used for anticoagulation purposes.
D: N/A This option provides no information or relevance to the question regarding thrombin inhibition, leaving it unaddressed in the context of pharmacological actions related to anticoagulants.
An LPN attending to chronic hypertensive elderly patients at the local skilled nursing facility should remember that use of beta adrenergic blockers can negate effects of
Rationale:
Beta 2 adrenergic agonists. Beta adrenergic blockers can impede the action of beta 2 adrenergic agonists, which are essential in treating conditions like asthma by promoting bronchodilation and improving airflow.
B: Bronchodilators. While bronchodilators include beta 2 agonists, not all bronchodilators are affected by beta adrenergic blockers, making this option less precise in addressing the question.
C: Both. This choice inaccurately generalizes the impact of beta adrenergic blockers, as they specifically negate the effects of beta 2 adrenergic agonists rather than all bronchodilators.
D: Neither. This option suggests no impact from beta adrenergic blockers, which contradicts established pharmacological principles regarding the interaction between these medications and beta adrenergic agonist effects.
Which of the following medications requires obtaining baseline prothrombin time (PT) and monitoring levels of PT and international normalized ratio (INR) periodically?
Rationale:
C: Vitamin K inhibitors require obtaining baseline prothrombin time (PT) and periodic monitoring of PT and international normalized ratio (INR) due to their mechanism of action, which affects blood coagulation, necessitating careful management to prevent bleeding complications.
A: Enoxaparin does not require baseline PT monitoring; it acts as a low molecular weight heparin with predictable anticoagulant effects, allowing for consistent dosing without routine PT assessments.
B: Fondaparinux does not involve PT or INR monitoring; it is a selective factor Xa inhibitor with a different pharmacological profile, allowing more straightforward management without the need for regular coagulation checks.
D: Heparin requires monitoring of activated partial thromboplastin time (aPTT) rather than PT or INR; its anticoagulant effects are gauged differently, focusing on aPTT to ensure effective dosing and safety.
Caution should be taken regarding clients who have been prescribed guaifenesin in the presence of asthma diagnosis because
Rationale:
Caution should be taken regarding clients who have been prescribed guaifenesin in the presence of asthma diagnosis because guaifenesin can cause bronchospasm.
Guaifenesin may stimulate the respiratory tract and lead to bronchospasm, which can exacerbate asthma symptoms. Patients with asthma are particularly sensitive to any medication that might trigger airway constriction, making it essential to monitor their response to guaifenesin closely.
B: guaifenesin can cause bronchoconstriction. This term does not accurately reflect the pharmacological effects of guaifenesin, which primarily relates to mucus clearance rather than direct bronchoconstriction.
C: guaifenesin can cause decreased diameter of bronchial lumina. Guaifenesin’s primary action is to expectorate mucus and does not directly affect the size of bronchial lumens in a way that would cause concern.
D: All of the above. While guaifenesin has effects on the respiratory system, not all the options accurately represent its pharmacological profile or its implications for asthma patients.
A patient is presented with weakness of legs, arms, trunk, tingling and numbness that progressively worsens. Peripheral blood smear shows macrocytic anemia. Which of the following is not the factor causing this condition?
Rationale:
A patient with macrocytic anemia and neurological symptoms likely has vitamin B12 deficiency, often caused by conditions affecting absorption. Alcoholism does not primarily interfere with vitamin B12 absorption, unlike the other factors listed.
A: Chronic atrophic gastritis leads to reduced intrinsic factor, impairing vitamin B12 absorption and resulting in macrocytic anemia and neurological symptoms.
B: Ileal resection removes the site where vitamin B12 is absorbed, causing deficiency that manifests as anemia and neurological complications over time.
C: Tapeworm infestation can lead to vitamin B12 deficiency by consuming the vitamin in the host's intestines, resulting in anemia and neurological symptoms associated with deficiency.
A nurse is attempting to relieve her patient's bronchospasm with Ipratropium should understand that the expected mechanism of action for this medication is
Rationale:
Blocking muscarinic receptors of the bronchi, resulting in bronchodilation. This mechanism enables Ipratropium to reduce bronchospasm effectively by preventing acetylcholine from binding to these receptors, leading to relaxation of airway smooth muscles and improved airflow.
A: Antagonizing b2 adrenergic receptors of the bronchi, resulting in bronchoconstriction. This action would promote airway narrowing rather than dilation, which contradicts the intended therapeutic effect of relieving bronchospasm.
C: Agonizing muscarinic receptors of the bronchi, resulting in bronchodilation. Activating muscarinic receptors would actually cause bronchoconstriction, opposing the desired outcome of improving airflow and alleviating bronchospasm.
D: Antagonizing a 1 adrenergic receptors of the myocardium. This option pertains to cardiac function, not respiratory mechanisms, and does not address the treatment of bronchospasm in the lungs.
A patient will be receiving a thrombolytic drug as part of the treatment for acute myocardial infarction. The nurse explains to the patient that this drug is used for which purpose?
Rationale:
To dissolve the clot in the coronary artery. Thrombolytic drugs are specifically designed to break down fibrin, facilitating the restoration of blood flow in blocked coronary arteries, thereby improving heart function and minimizing damage during an acute myocardial infarction.
A: To control bleeding in the coronary vessels. Thrombolytics are not intended to manage bleeding; rather, their primary function is to dismantle clots obstructing blood flow in coronary arteries.
C: To relieve chest pain. While thrombolytics can indirectly alleviate pain by restoring blood flow, their primary purpose is to address the underlying issue of the clot itself.
D: To prevent further clot formation. Thrombolytic agents focus on dissolving existing clots rather than preventing new ones from forming, which is the role of antiplatelet medications.
Heparin, an anticoagulant and naturally occurring glycosaminoglycan, exerts its pharmacological effects on the clotting cascade by activating antithrombin, thus indirectly inactivating both
Rationale:
Heparin activates antithrombin, leading to the inactivation of thrombin and factor Xa, key components in the coagulation cascade. This process effectively prevents clot formation and maintains blood fluidity.
B: prothrombin and factor X. Prothrombin is not directly inactivated by heparin; rather, it is converted to thrombin, which heparin targets through antithrombin activation.
C: von Willebrand factor and factor IX. Heparin does not affect von Willebrand factor directly; it primarily focuses on thrombin and factor Xa to regulate coagulation.
D: Tissue factor and factor XIa. Tissue factor is not a target of heparin; it plays a role in initiating the coagulation cascade, while heparin works downstream through antithrombin.
Anticoagulants are indicated in
Rationale:
Anticoagulants are indicated in all of these. Anticoagulants help prevent blood clots, making them essential for immobilized elderly patients to reduce thromboembolism risk, for managing Buerger's disease complications, and for treating strokes caused by cerebral thrombosis. Each condition benefits from anticoagulation therapy to enhance patient outcomes and minimize serious complications.
A: Immobilized elderly patients. This group faces heightened risk of venous thromboembolism, necessitating anticoagulation to mitigate potential clot formation during prolonged immobility.
B: Buerger's disease. While this condition involves blood vessel inflammation and clotting, anticoagulants are not typically indicated as the primary treatment for managing Buerger's disease.
C: Stroke due to cerebral thrombosis. Although anticoagulants can be beneficial, not all cerebral thrombosis cases warrant such treatment; other interventions may be prioritized based on specific circumstances.
A 50 year old male who had frequent infections of his upper respiratory tract manifested with subcutaneous petechiae over his arms and legs. Investigations revealed low haemoglobin and a dry tap marrow. The most likely condition the patient is suffering from
Rationale:
Aplastic anaemia. The patient's symptoms, including frequent infections, subcutaneous petechiae, low haemoglobin, and a dry tap marrow, indicate a failure of the bone marrow to produce sufficient blood cells, characteristic of aplastic anaemia.
A: Iron deficiency anaemia. This condition typically presents with fatigue and pallor but does not cause frequent infections or petechiae, indicating a different underlying mechanism than observed here.
B: Megaloblastic anaemia. While it involves low haemoglobin and can cause fatigue, it is characterized by larger than normal red blood cells, not the dry tap marrow seen in this patient.
C: Haemolytic anaemia. This type involves the destruction of red blood cells, leading to jaundice and elevated bilirubin levels, which do not align with the patient's symptoms or investigative findings.
Which of the following PO beta2 adrenergic agonists is used for long term control of chronic COPD as well as for emergency IV treatment of bronchospasms?
Rationale:
D: Albuterol is utilized for long-term management of chronic COPD and serves as an emergency treatment for bronchospasms when delivered intravenously, providing rapid bronchodilation and improved airflow.
A: Theophylline functions primarily as a bronchodilator but lacks the fast-acting properties required for emergency treatment and is not typically favored for acute bronchospasm scenarios in COPD.
B: Acetylcysteine acts as a mucolytic agent, aiding in mucus clearance, but does not possess bronchodilating effects necessary for treating bronchospasms or managing COPD over the long term.
C: Codeine is an opioid cough suppressant and does not serve any role in bronchodilation or the management of COPD, making it unsuitable for treating bronchospasms or chronic conditions.
The typical Reed-Sternberg cells are either infrequent or absent. Instead, lymphocytic and histiocytic cells or “popcorn cells†are seen within a background of inflammatory cells, which are predominantly benign lymphocytes. Which type of Hodgkin's lymphoma best suit the description?
Rationale:
Lymphocyte predominance describes Hodgkin's lymphoma characterized by the presence of lymphocytic and histiocytic cells or "popcorn cells," with typical Reed-Sternberg cells being either infrequent or absent.
A: Nodular sclerosis features distinct Reed-Sternberg cells within fibrous bands, making it unsuitable for this description, which emphasizes the scarcity of these typical cells.
B: Mixed cellularity is marked by a diverse array of cells, including abundant Reed-Sternberg cells, contrasting with the absence highlighted in the question's context regarding lymphocyte predominance.
C: Lymphocyte depleted presents a lack of lymphocytes and a predominance of Reed-Sternberg cells, directly opposing the scenario described where lymphocytes are notably present.
Which of the following is the most suitable anti malarial drug for pregnant women?
Rationale:
Quinine and clindamycin are the most suitable anti-malarial drugs for pregnant women. This combination is effective against malaria and has a more favorable safety profile for both mothers and fetuses compared to other options available.
A: Atovaquone and proguanil lacks sufficient safety data for use in pregnancy, posing potential risks that make it unsuitable for treating malaria in pregnant women.
B: Quinine and doxycycline presents concerns due to doxycycline's contraindication during pregnancy, where it may adversely affect fetal development and is not recommended for this population.
D: Primaquine is contraindicated in pregnancy due to its potential to cause hemolysis in the fetus, making it an unsafe choice for pregnant women needing anti-malarial treatment.
After seven days of treatment with sulfonamides a patient's haemoglobin had decreased from 14.7 gm/100 ml to 10 gm/100 ml. The most likely cause of hemolysis in this patient is
Rationale:
D: Glucose 6-phosphate dehydrogenase deficiency (G6PD) is the most likely cause of hemolysis in this patient due to the known association between sulfonamide treatment and oxidative stress in G6PD-deficient individuals, leading to significant hemolytic anemia.
A: Sickle cell disease results in chronic hemolysis but is less likely to be triggered acutely by sulfonamides, which do not typically provoke vaso-occlusive crises in this condition.
B: Thalassemia minor involves structural hemoglobin issues rather than hemolysis induced by medication; it primarily leads to microcytic anemia without significant hemolytic episodes following sulfonamide administration.
C: Hereditary spherocytosis causes hemolysis but is not linked to sulfonamide use. This condition stems from membrane defects in red blood cells, not from drug-induced oxidative damage.
Which of the following is false regarding Burkitt's lymphoma?
Rationale:
Burkitt's lymphoma is associated with the translocation of the c-myc gene on chromosome 8, not chromosome 18. This genetic alteration plays a crucial role in the pathogenesis of Burkitt's lymphoma, making option A false.
B: Usually presents with abdominal involvement in HIV patients. Abdominal involvement is a typical presentation of Burkitt's lymphoma, particularly in immunocompromised individuals, including those with HIV.
C: Common in African children due to Epstein Barr infection after malaria exposure. Burkitt's lymphoma is notably prevalent in African children, linked to Epstein-Barr virus and malaria interactions that enhance susceptibility.
D: Histologically characterized by a “starry sky” appearance. The “starry sky” pattern is a hallmark histological feature of Burkitt's lymphoma, resulting from an abundance of macrophages and tumor cells.